GFM
CRL icon

GF Fund Management’s Charles River Laboratories CRL Stock Holding History

GF Fund Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Buy
1,339
+14
+1% +$2.49K ﹤0.01% 241
2026
Q1 		$229K Hold
1,325
– – ﹤0.01% 274
2025
Q4 		$264K Sell
1,325
-23
-2% -$4.17K ﹤0.01% 266
2025
Q3 		$211K Buy
1,348
+126
+10% +$20K ﹤0.01% 290
2025
Q2 		$185K Sell
1,222
-9
-0.7% -$1.2K ﹤0.01% 324
2025
Q1 		$185K Hold
1,231
– – ﹤0.01% 324
2024
Q4 		$227K Buy
+1,231
New +$237K ﹤0.01% 279

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

GF Fund Management's CRL Position: Q2 2026 in Review

GF Fund Management increased its Charles River Laboratories (CRL) stake by 1.1% in Q2 2026, buying an estimated $2.49K and bringing the position to 1,339 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #241.

GF Fund Management first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • GF Fund Management held 1,339 shares of Charles River Laboratories worth $304K as of Q2 2026.
  • GF Fund Management bought 14 Charles River Laboratories shares in Q2 2026, an estimated $2.49K.
  • Charles River Laboratories made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #241 holding.
  • GF Fund Management first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.